Summary:
- Pfizer is seeking FDA approval for a new Lyme disease vaccine. This vaccine could provide protection against the bacteria that causes Lyme disease, which is transmitted through tick bites.
- Lyme disease is a serious illness that can lead to various health problems if left untreated, including joint pain, neurological issues, and heart problems. A safe and effective vaccine could help prevent many people from contracting this disease.
- The vaccine is currently in late-stage clinical trials, and Pfizer is hopeful that it will be approved for use in the near future. This could be a significant development in the fight against Lyme disease, which has been a growing public health concern in many parts of the world.